psychminded.co.uk
News
 
x home   x
x
x courses    
x conferences    
x archive/big issues    
x comment    
x books - new & used    
x members forum    
x contact us    
x advertise your jobs, courses & conferences    


New and second-hand psychology psychiatry and mental health books...


Get email news updates at the members forum


Email a colleague
about this article

 

 


Company 'held back' data on SSRI anti-depressants for children

February 8, 2004

The Guardian newspaper has reported that British manufacturers of the SSRI antidepressant, Seroxat, that was last year banned for children, knew in 1998 that it was not effective.

The newspaper said that the company deliberately avoided publishing the full data because of the risk to their lucrative adult market. This was according to a leaked internal document.

The Guardian wrote that a position paper dated October 1998 shows that managers at SmithKline Beecham - now GlaxoSmithKline (GSK) - were concerned at the commercial implications of two clinical trials in which their drug Seroxat was given to children and adolescents with major depression.

However, Alastair Benbow, GSK's head of European clinical psychiatry, was quoted as saying that the document "draws inappropriate conclusions and it is inconsistent with the facts".

Meanwhile the British Medical Journal reported that in the United States scientific advisers to the Food and Drug Administration urged the agency to warn that SSRIs may increase the risk of suicidal thinking or behaviour among children and teenagers.

The BMJ reported that experts weighed the official presentations of uncertain scientific data against powerful emotional testimony from dozens of families whose children have killed themselves or others after taking SSRIs — a class including fluoxetine (Prozac), sertraline (Zoloft), and paroxetine (Paxil, Seroxat).

The advisers also decided to recommend "stronger warnings" about the suicide risks.

In 2002 almost 11 million prescriptions of selective serotonin reuptake inhibitors were written for people under 18, including more than five million for sertraline and paroxetine—neither of which are approved for children in the United States.

See also:
Dec, 2003: Medicines and Healthcare products Regulatory Agency's advice on SSRIs and children sent to psychiatrists and other mental health professionals (pdf)

Dec 14, 2003: Agency rules that SSRIs should not be prescribed for children

Share/Bookmark
Add your comments
What do you think? Email your comments on the above
article to the editor using the form below. Selected comments will be displayed.

First name:
Last name:
Current position:
Place of work:
E-mail address:
Story commenting upon: (type in article headline)
Comments: (you may find it easier to copy and paste from a word file)
 

© 2001-7  Psychminded Limited. All rights reserved

Email a colleague
about this article

 

 

 

 


Nottingham Trent University courses



Receive job and news updates by email



April 9, 2008: This tide's already changed - The recovery approach in mental health is not new say Phil Barker and Poppy Buchanan-Barker.
Feb 16, 2011: Crisis of masculinity? Time for psychologists to study men- Martin Seager explains why in a society where almost all prisoners are men psychologists should focus more on male psychology.

Oct 9, 2008: Cognitive behavioural therapy; a Labour quick fix
- CBT simplifies what distress is, argues Dorothy Rowe

March 20, 2008: 'Recovery' approach in mental health is idea 'whose time has come' - charity bids to present principles behind “empowering” philosophy of care

Oct 31, 2007: Getting personal - Stop the psychological therapy "brand warfare" argues Martin Seager


Do you need a conference or events photographer?